Atreca, Inc. - (BCEL): Price and Financial Metrics
BCEL Price/Volume Stats
| Current price | $0.09 | 52-week high | $1.20 |
| Prev. close | $0.09 | 52-week low | $0.05 |
| Day low | $0.09 | Volume | 138,600 |
| Day high | $0.10 | Avg. volume | 4,609,200 |
| 50-day MA | $0.09 | Dividend yield | N/A |
| 200-day MA | $0.20 | Market Cap | 3.57M |
BCEL Stock Price Chart Interactive Chart >
Atreca, Inc. - (BCEL) Company Bio
Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman in June 11, 2010 and is headquartered in Redwood, CA.
BCEL Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 5.88% |
| 1-year | -57.14% |
| 3-year | -98.03% |
| 5-year | -99.08% |
| YTD | -31.82% |
| 2023 | -83.51% |
| 2022 | -73.58% |
| 2021 | -81.24% |
| 2020 | 4.40% |
| 2019 | N/A |
Loading social stream, please wait...